Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. It develops the Afirma Gene Sequencing Classifier, which examines gene expression patterns in thyroid nodules; the Prosigna Breast Cancer Assay, a diagnostic test for breast cancer; the Envisia Genomic Classifier, which is used to diagnose interstitial lung disease, including idiopathic pulmonary fibrosis; etc. The company also provides transcriptomics, genomic testing, clinical development, and in vitro diagnostics (IVD) services for biopharmaceutical and diagnostics companies.